Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of COV155 in Osteoarthritis or Chronic Low Back Pain
NCT01722864Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Nov 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocodone, acetaminophen in osteoarthritis (OA), chronic low back pain (CLBP), sponsored by Mallinckrodt Pharmaceuticals. Started Nov 2012; status: completed.
02
Drugs
hydrocodoneacetaminophen
03
Conditions
osteoarthritis (OA)chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01722864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722864.